Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

NCT02224456 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Tenofovir disoproxil fumarate

Sponsor

GlaxoSmithKline